Breaking News, Trials & Filings

Trials & Filings: Oct. 23, 2013

Lilly, Merck

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Filings FDA grants Lilly’s ramucirumab Priority Review… read more Merck receives Breakthrough Designation for HCV drug… read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters